At week 4 , your prescriber will typically increase your dose to 5 mg weekly, provided you have tolerated the initial 2.5 mg dose
Overlap exists in their ultimate outcome (weight management), but their mechanisms do not directly amplify each other
We may also contact you via surveys to conduct research about your opinion of current services or of potential new services that may be offered
Nut Butter with Apple or Celery Two tablespoons of nut butter yield 68g protein
Contact your healthcare provider immediately if you experience: Severe or persistent abdominal pain , particularly if localized to the upper abdomen or accompanied by back pain, which could indicate pancreatitisa rare but serious adverse effect documented in tirzepatide clinical trials Right upper quadrant pain, fever, or yellowing of skin/eyes , which may indicate acute gallbladder disease, a known risk with tirzepatide therapy Persistent nausea and vomiting that prevents adequate oral intake or leads to signs of dehydration (decreased urination, dizziness, dry mouth, extreme thirst) Severe diarrhea lasting more than 48 hours or accompanied by fever, bloody stools, or severe cramping, which may indicate gastrointestinal infection or other complications Severe abdominal distention, inability to pass gas or stool, and persistent vomiting , which could indicate intestinal obstruction Inability to tolerate any food or liquids for more than 24 hours, as this poses risks for dehydration and electrolyte imbalances Unexplained weight loss beyond expected therapeutic effects, or difficulty maintaining adequate nutrition Patients taking tirzepatide with insulin or sulfonylureas should also be alert for hypoglycemia symptoms (shakiness, dizziness, sweating, confusion) and seek prompt care if severe
Youre Having Severe Cramps Mild increases in cramps can happen, but pain that feels sharp, severe, or unusual for you shouldnt be ignored
